Overview
Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding
Description
Participants with acute esophagogastric variceal bleeding in 5 days and under stable status will be included in this study. All the patients will take CTP test to confirm the blood flow status of the portal vein before endoscopic treatment. After that they will be randomly divided into two groups: A. accept growth inhibitors after the endoscopic treatment for 5 days; B. no growth inhibitor will be applied after the treatment.
Eligibility
Inclusion Criteria:
- acute esophagogastric bleeding with hepatic cirhosis;
- stable status (no active bleeding)
Exclusion Criteria:
- endoscopic test limitation;
- previous acute esophagogastric bleeding treatment history;
- ICU;
- pregnant;
- Immunity disabled;